Publications by authors named "Xuebing Fu"

Claim this Profile
O
Optimization of First-Line Treatment Options in HER2-Altered Lung Adenocarcinoma: A Real-World Study.
Xiufen Wang, Dahai Wang, Yanxin Sun, Yiling Gan, Juan Li, Xuebing Fu

Cancer Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin-like transcript 5 polarizes M2-like tumor-associated macrophages for immunosuppression in non-small cell lung cancer.
Huijun Xu, Xuebing Fu, Shuyun Wang, Yihui Ge, Lu Zhang, Yifu He

Int J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma.
Leirong Wang, Qing Li, Yanxin Sun, Shuyun Wang, Xuebing Fu

Transl Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC.
Xiufen Wang, Xuebing Fu, Qiaohong Liu, Juan Li, Yihui Ge

BMC Pulm Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ILT4 facilitates angiogenesis in non-small cell lung cancer.
Shuyun Wang, Jing Wang, Wenjing Gong, Fang Zhang, Xiaozheng Chen, Xuebing Fu

Cancer Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective sampling of transition paths.
Xuebing Fu, Lijiang Yang, Yi Qin Gao

J Chem Phys· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis